CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-04 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −32,291 | 17,709 | ||
| 2020-12-04 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −16,709 | 5,791 | ||
| 2020-12-03 | Anicetti Vincent R Chief Operating Officer | Option exercise | +36,736 | $17.17 | $631K | 69,305 |
| 2020-12-03 | Anicetti Vincent R Chief Operating Officer | Option exercise | +13,020 | $17.73 | $231K | 82,325 |
| 2020-12-03 | Anicetti Vincent R Chief Operating Officer | Sale | −49,756 | $18.67 | $929K | 32,569 |
| 2020-12-03 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −36,736 | 0 | ||
| 2020-12-03 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −13,020 | 49,480 | ||
| 2020-11-18 | Anicetti Vincent R Chief Operating Officer | Option exercise | +4,283 | $12.70 | $54K | 36,852 |
| 2020-11-18 | Anicetti Vincent R Chief Operating Officer | Sale | −4,283 | $18.00 | $77K | 32,569 |
| 2020-11-18 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −4,283 | 22,500 | ||
| 2020-11-17 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $2.50 | $6K | 51,056 |
| 2020-11-17 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $17.50 | $44K | 48,556 |
| 2020-11-17 | Anicetti Vincent R Chief Operating Officer | Sale | −12,420 | $17.68 | $220K | 36,136 |
| 2020-11-17 | Anicetti Vincent R Chief Operating Officer | Sale | −3,567 | $17.68 | $63K | 32,569 |
| 2020-11-17 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 7,488 | ||
| 2020-11-17 | Viret Jean-Frederic Chief Financial Officer | Sale | −1,995 | $17.49 | $35K | 38,769 |
| 2020-11-17 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +1,500 | $13.50 | $20K | 40,269 |
| 2020-11-17 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −1,500 | 110,241 | ||
| 2020-10-19 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $2.50 | $6K | 51,056 |
| 2020-10-19 | Anicetti Vincent R Chief Operating Officer | Option exercise | +717 | $12.70 | $9K | 51,773 |
Page 13 of 39 · 768 trades